The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7927601 B1

PDF
Full Text
Expired
Date of Patent:
Apr. 19, 2011

Filed:

Sep. 28, 2005
Applicants:

Julie Sheldon, Madrid, ES;

Berta Rodes, Madrid, ES;

Vincent Soriano, Madrid, ES;

Angeline Ingrid Bartholomeusz, Carnegie, AU;

Inventors:

Julie Sheldon, Madrid, ES;

Berta Rodes, Madrid, ES;

Vincent Soriano, Madrid, ES;

Angeline Ingrid Bartholomeusz, Carnegie, AU;

Assignees:

Melbourne Health, Parkville, Victoria, AU;

Fundacion Investigacion y Educacion En Sida, Madrid, ES;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/70 (2006.01); C12N 7/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates generally to viral variants exhibiting reduced sensitivity to particular agents and/or reduced interactivity with immunological reagents. More particularly, the present invention is directed to hepatitis B virus (HBV) variants exhibiting complete or partial resistance to nucleoside or nucleotide analogs or other antagonists of HBV DNA polymerase activity and/or reduced interactivity with antibodies to viral surface components including reduced sensitivity to these antibodies. The present invention further contemplates assays for detecting such viral variants. These assays are useful in monitoring anti-viral therapeutic regimens and in developing new or modified vaccines directed against viral agents and in particular the resistant HBV variants of the present invention. The present invention also contemplates the use of the viral variants to screen for agents capable of inhibiting infection, replication and/or release of the virus.


Find Patent Forward Citations

Sheldon, Julie. (2011). Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof (U.S. Patent No. 7927601). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7927601

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…